(Q61218080)
Statements
The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy (English)
Schlomo Staszewski
Errol Babacan
Christoph Stephan
Annette Haberl
Amina Carlebach
Peter Gute
Stephan Klauke
Yvonne Hermschulte
Martin Stuermer
Brenda Dauer
Frankfurt HIV Cohort
6 September 2006